The rising incidence of cancer, growing healthcare expenditure, improving infrastructure of cancer diagnosis, and technological advancements in tissue diagnostics are driving the growth of the global market. Moreover, significant opportunities in BRICS countries, growing demand for personalized medicines, and increasing number of clinical trials pertaining to cancer drugs are expected to create...